Toth Financial Advisory Corp Exelixis, Inc. Transaction History

Toth Financial Advisory Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	BUY	$19.04 - $22.74 $571,200 - $682,200	30,000 New	30,000 $655,000
Q2 2019 Jul 17, 2019	SELL	$18.93 - $24.75 $403,682 - $527,793	-21,325 Closed	0 $0
Q1 2019 Apr 15, 2019	BUY	$19.6 - $24.76 $417,970 - $528,007	21,325 New	21,325 $508,000

508

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.